Gilead Sciences to Present at the Credit Suisse 2013 Healthcare Conference on Wednesday, November 13

  Gilead Sciences to Present at the Credit Suisse 2013 Healthcare Conference
  on Wednesday, November 13

              Webcast Available Through Gilead Corporate Website

Credit Suisse Healthcare Conference 2013

Business Wire

FOSTER CITY, Calif. -- November 12, 2013

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the Credit Suisse 2013 Healthcare Conference
in Scottsdale, Arizona.

Kevin Young CBE, Gilead’s Executive Vice President, Commercial Operations,
will provide an overview of the company at the conference on Wednesday,
November 13 at 10:00 a.m. Mountain Time.

To access the live webcast or a replay via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North and South America, Europe and Asia Pacific.

 For more information on Gilead Sciences, please visit www.gilead.com or call
   the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contact:

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations